New study shows long-term durability of early combination therapy in patients newly diagnosed with type 2 diabetes
A new study, VERIFY (Vildagliptin Efficacy in combination with metfoRmIn For earlY treatment of type 2 diabetes) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, ...
Sep 18, 2019
0
4